SCHEMBL4758239

SCHEMBL4758239

NNC(=O)c1cc(Cl)cc(N2CCOCC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.47
MAPT P10636 8/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMO O15229 1/20 0.46
HPGD P15428 1/20 0.45
GSK3B P49841 1/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.43
HTT P42858 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPK1 P28482 1/20 0.43
PLOD2 O00469 1/20 0.43
PLOD3 O60568 1/20 0.43
PLOD1 Q02809 1/20 0.43
MCL1 Q07820 1/20 0.43
DDR1 Q08345 1/20 0.42
AKR1C3 P42330 1/20 0.42
LRRK2 Q5S007 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27472161 0.83 MAP2 (0.49) MAPTSMN1; SMN2ALDH1A1TDP1KMO
SCHEMBL4755079 0.82 DDR1 (0.47) MAPTALDH1A1LMNAKMT2APLOD2
SCHEMBL4757032 0.81 KMO (0.62) MAPTSMN1; SMN2ALDH1A1TDP1KMO
SCHEMBL12524169 0.80 HDAC6 (0.61) MAPTSMN1; SMN2ALDH1A1TDP1HPGD
SCHEMBL14697008 0.79 KMO (0.68) MAPK14MAPTSMN1; SMN2ALDH1A1TDP1
SCHEMBL24236054 0.77 PRKDC (0.54) MAPTSMN1; SMN2ALDH1A1TDP1LMNA
SCHEMBL1252295 0.77 CHRM2 (0.57) MAPTSMN1; SMN2ALDH1A1LMNAMEN1
SCHEMBL4755128 0.77 MAPK14 (0.44) MAPK14MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL4755106 0.76 PIK3CA (0.55) MAPTSMN1; SMN2ALDH1A1TDP1HPGD
SCHEMBL21638091 0.75 KDM4E (0.61) MAPTALDH1A1TDP1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed
WO-2009000819-A1 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 WO disclosed